(NASDAQ:SRPT), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. (“Sarepta” or “the Company”) (NASDAQ: SRPT) and certain of its officers. Class Definition This lawsuit seeks to recover damages […]

(NYSE:FI), NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Fiserv, Inc. (“Fiserv” or “the Company”) (NYSE: FI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against

SRPT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sarepta Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action

FI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Fiserv, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit GlobeNewswire August 01, 2025 NEW YORK, Aug. 01, 2025 (GLOBE NEWSWIRE) — Attorney Advertising — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit

(NasdaqGM:RCKT), Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 01, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Rocket Pharmaceuticals, Inc. (“Rocket Pharmaceuticals” or the “Company”) (NASDAQ: RCKT) investors of a class action representing investors that bought securities between February 27, 2025 and

Rocket Pharmaceuticals, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. August 11, 2025 Deadline to file Lead Plaintiff Motion. GlobeNewswire August 01, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Aug. 01, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm

(NasdaqGM:TVGN),(NASDAQ:TVGNW), WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic enterprise expanding into artificial intelligence through Tevogen.AI. Our mission remains steadfast: delivering clinically impactful, economically accessible therapies

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders GlobeNewswire August 01, 2025 WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders. Dear Fellow Stockholders, Tevogen has rapidly evolved from a biotechnology innovator into a dynamic

The future of the National Mental Health Corps (NMHC)- a leading pipeline into the mental health workforce-is now in jeopardy. In the midst of a growing mental health crisis, the loss of AmeriCorps funding for crisis call center placements-and the emerging threat to suicide prevention training support-marks a critical moment for the National Mental Health

(NYSE:NVO), Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Novo To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Novo between May 7, 2025, to July 28, 2025 and would like to discuss your legal rights, call Faruqi &